Friday, May 16, 2025
5/16/2025
Elucidating the Role of cGAS-STING in Lung Tissue Repair and Remodeling - PROJECT SUMMARY Idiopathic pulmonary fibrosis is a chronic, progressive, highly heterogeneous fibrotic lung disease. The median survival from the time of diagnosis is ~3 years, demonstrating that IPF is considered more lethal than many cancers. There is no identifiable cause for most patients with IPF. Current FDA-approved drugs only slow progression but do not cure IPF. The pathophysiology of pulmonary fibrosis relies on repeated local micro- injuries to the alveolar epithelium triggering DNA damage, cell death, and aberrant lung tissue remodeling. Elevated levels of cell-free double-stranded DNA (dsDNA) serve as a negative predictive factor for fatal outcomes in IPF patients. dsDNA in the cytoplasm is recognized by cGAS-STING (stimulator of interferon genes); cGAS-STING is activated in fibrotic lung tissue from interstitial lung disease patients. cGAS-STING promotes the translocation of IFN regulatory factor 3 (IRF3) and NF-κB to the nucleus, inducing type I IFNs and other proinflammatory cytokines. Using a well-defined, murine model of pulmonary fibrosis, we find increased dsDNA in BALF of injured mice. Critically, Cgas-/- mice show reduced inflammation, decreased lung collagen levels, and improved static lung compliance compared to WT mice. Recently, STING was found to interact with vimentin, a protein critical for cell structure and organelle positioning. Given our previous report that Vimentin-/- mice are protected from bleomycin-induced lung injury and fibrosis, together with evidence that vimentin facilitates STING ER-to-Golgi trafficking, an essential and rate-limiting step in activating cGAS-STING, we hypothesize persistent activation of cGAS-STING signaling in alveolar epithelial cells and alveolar macrophages contributes to aberrant lung tissue repair. Specific Aim 1: Determine whether cGAS-STING-mediated IRF3 and NF-kB activation in monocyte- derived alveolar macrophages is necessary for aberrant lung tissue remodeling associated with pulmonary fibrosis. We will genetically inhibit cGAS-STING-mediated IRF3 and NF-kB signaling in MoAM during the fibrotic phase of bleomycin injury and use complementary physiologic and molecular techniques to assess lung repair. Specific Aim 2. Determine the mechanism by which VIM-cGAS-STING axis contributes to aberrant lung tissue repair and pulmonary fibrosis. We will define the mechanism by which VIM, a STING- interacting protein, traffics STING from the ER-to-Golgi, initiating STING-dependent IRF3 and NF-κB signaling leading to the expression of type I IFNs and inflammatory cytokines. Specific Aim 3. Determine whether cGAS- STING–PERK signaling is required for alveolar epithelial cell damage/stress and pulmonary fibrosis. Our data shows that cGAS-STING is activated in alveolar epithelial cells from patients with pulmonary fibrosis. Upon binding to cGAMP, STING binds to and directly activates the ER-located kinase PERK in the endoplasmic reticulum (ER). We will address whether the STING-PERK axis is required for alveolar epithelial cell damage/stress and contributes to aberrant lung tissue remodeling associated with pulmonary fibrosis.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).